IndraLab

Statements


PLP2 inhibits ZUP1. 7 / 7
| 3 4

eidos
"We found that mutating 42 the ubiquitin-binding residues results in a PLP2 that has reduced DUB activity but retains protease 43 activity ."
| DOI

reach
"For example, the mutations D91R and T88R largely blocked the PLP2 activity and E90R partially blocked the DUB activity (Figure 4)."

reach
"We found that mutating the ubiquitin-binding residues results in a PLP2 that has reduced DUB activity but retains protease activity."
| DOI

eidos
"We found that mutating the ubiquitin-binding residues results in a PLP2 that has reduced DUB activity but retains protease activity ."
| DOI

reach
"We found that mutating 42 the ubiquitin-binding residues results in a PLP2 that has reduced DUB activity but retains protease 43 activity."
| DOI

eidos
"We found that mutating the ubiquitin-binding residues results in a PLP2 that has reduced DUB activity but retains protease activity ."

reach
"We found that mutating the ubiquitin-binding residues results in a PLP2 that has reduced DUB activity but retains protease activity."